Tred Avon Family Wealth LLC Takes Position in The Clorox Company $CLX

Tred Avon Family Wealth LLC bought a new stake in shares of The Clorox Company (NYSE:CLX) during the 1st quarter, HoldingsChannel.com reports. The fund bought 6,402 shares of the company’s stock, valued at approximately $663,000.

Other institutional investors have also bought and sold shares of the company. State Street Corp raised its holdings in shares of Clorox by 3.5% in the third quarter. State Street Corp now owns 8,434,277 shares of the company’s stock valued at $1,039,946,000 after purchasing an additional 282,794 shares during the last quarter. Invesco Ltd. boosted its holdings in Clorox by 22.1% during the fourth quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock worth $492,085,000 after purchasing an additional 884,751 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Clorox by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock worth $318,613,000 after purchasing an additional 10,060 shares during the last quarter. Van ECK Associates Corp grew its position in Clorox by 15.7% in the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock worth $316,244,000 after purchasing an additional 426,433 shares in the last quarter. Finally, Two Sigma Investments LP increased its stake in Clorox by 33.8% in the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after buying an additional 439,797 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Insider Activity

In other news, Director Pierre R. Breber bought 5,000 shares of the stock in a transaction on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares in the company, valued at $1,544,760. This represents a 38.46% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.63% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Evercore restated an “underperform” rating and issued a $110.00 target price on shares of Clorox in a research note on Friday, May 1st. Wells Fargo & Company decreased their price target on Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research report on Monday, May 18th. Citigroup dropped their price target on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Royal Bank Of Canada cut their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. Finally, Barclays reduced their price objective on Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus price target of $103.40.

Clorox Trading Down 0.0%

Shares of CLX stock opened at $97.51 on Monday. The company has a 50 day moving average of $94.67 and a 200-day moving average of $104.45. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $132.03. The firm has a market cap of $11.79 billion, a P/E ratio of 15.83, a PEG ratio of 0.51 and a beta of 0.56.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the prior year, the business earned $1.45 earnings per share. Clorox’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Sell-side analysts anticipate that The Clorox Company will post 5.61 earnings per share for the current year.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.